Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Reusch

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of the American Society of Nephrology : JASN|June 5, 2020
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in JapanTadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, et al.
Journal of Clinical Medicine|July 14, 2023
Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney DiseaseTomas Ganz, Francesco Locatelli, Mustafa Arici, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]Thomas Luger, Michael Reusch, Kristian Reich, et al.
Advances in Therapy|April 7, 2019
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled TrialTadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 1, 2015
[Association of Health Insurance and Socio-economic Factors with Health Care for Malignant Melanoma]Ines Schäfer, Michael Reusch, Julia Siebert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 2, 2014
Health care characteristics of basal cell carcinoma in Germany: the role of insurance status and socio-demographic factorsInes Schäfer, Michael Reusch, Julia Siebert, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2020
Authors' ReplyTadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, et al.
Kidney International Reports|July 26, 2021
Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKDTadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2010
Routine skin cancer screening in Germany: First data on the impact on health care in dermatologyMatthias Augustin, Christine Blome, Stephan Jeff Rustenbach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 19, 2007
[Dermatological guideline efforts for 2007 in perspective]Hans Christian Korting, Richard Callies, Michael Reusch, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of the American Society of Nephrology : JASN|June 5, 2020
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in JapanTadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, et al.
Journal of Clinical Medicine|July 14, 2023
Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney DiseaseTomas Ganz, Francesco Locatelli, Mustafa Arici, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[Statement of the DDG and the BVDD on the EMEA recommendations the use of raptiva [efalizumab]]Thomas Luger, Michael Reusch, Kristian Reich, et al.
Advances in Therapy|April 7, 2019
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled TrialTadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|December 1, 2015
[Association of Health Insurance and Socio-economic Factors with Health Care for Malignant Melanoma]Ines Schäfer, Michael Reusch, Julia Siebert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 2, 2014
Health care characteristics of basal cell carcinoma in Germany: the role of insurance status and socio-demographic factorsInes Schäfer, Michael Reusch, Julia Siebert, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2020
Authors' ReplyTadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, et al.
Kidney International Reports|July 26, 2021
Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKDTadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2010
Routine skin cancer screening in Germany: First data on the impact on health care in dermatologyMatthias Augustin, Christine Blome, Stephan Jeff Rustenbach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 19, 2007
[Dermatological guideline efforts for 2007 in perspective]Hans Christian Korting, Richard Callies, Michael Reusch, et al.
Pageof 5